4.7 Article

Keeping Meta-Analyses Hygienic During the COVID-19 Pandemic

Related references

Note: Only part of the references are listed.
Review Rheumatology

Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis

Michael Putman et al.

Summary: In this systematic review and meta-analysis, the use of hydroxychloroquine was not found to be associated with benefits or harm in terms of COVID-19 mortality. The evidence regarding the effectiveness of other antirheumatic disease therapies in COVID-19 is currently inconclusive.

ARTHRITIS & RHEUMATOLOGY (2021)

Review Infectious Diseases

Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis

Thibault Fiolet et al.

Summary: This systematic review and meta-analysis found that hydroxychloroquine alone did not reduce mortality in hospitalized COVID-19 patients, while the combination of hydroxychloroquine and azithromycin significantly increased mortality.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Review Infectious Diseases

Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis

Zakariya Kashour et al.

Summary: The study included 7 RCTs and 14 cohort studies with a total of 20979 patients. Results indicated that HCQ lacks efficacy in reducing short-term mortality in COVID-19 hospitalized patients and the risk of hospitalization in outpatients. Additionally, the combination of HCQ and azithromycin also did not significantly impact mortality rates.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

Review Virology

Hydroxychloroquine for treatment of nonsevere COVID-19 patients: Systematic review and meta-analysis of controlled clinical trials

Hozaifa Khalil Elsawah et al.

Summary: Assessing the efficacy of hydroxychloroquine in treating COVID-19 showed significant effectiveness in preventing radiological progression while not showing clinical benefits or reducing mortality rates. Furthermore, adverse effects were reported with hydroxychloroquine therapy, indicating that the risks may outweigh the benefits in nonsevere COVID-19 patients.

JOURNAL OF MEDICAL VIROLOGY (2021)

Review Medicine, General & Internal

Systematic review and meta-analysis of the effectiveness and safety of hydroxychloroquine in treating COVID-19 patients

Tzu-Han Yang et al.

Summary: The meta-analysis included 9 trials with 4112 patients. The results indicated that the HCQ-AZI combination increased mortality rate in COVID-19 patients, but also showed benefits in terms of viral clearance. HCQ-alone treatment showed potential benefits in decreasing mortality rate among severely infected COVID-19 patients. Further high-quality studies with longer follow-up periods are needed to confirm these findings.

JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2021)

Review Pharmacology & Pharmacy

Hydroxychloroquine use and progression or prognosis of COVID-19: a systematic review and meta-analysis

Yanxiang Zang et al.

Summary: There is controversy surrounding the use of Hydroxychloroquine (HCQ) for COVID-19 treatment, and while it showed some impact on pneumonia exacerbation and disease progression, there was no substantial evidence to support its use based on the meta-analysis of seven studies involving 851 participants. The death rate in HCQ group was significantly higher compared to the standard treatment group for COVID-19.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2021)

Review Multidisciplinary Sciences

The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials

Kimberley Lewis et al.

Summary: The use of hydroxychloroquine as a prophylaxis for COVID-19 did not show significant reduction in the risks of infection, hospitalization, or mortality compared to placebo. However, it increased the risk of adverse events. Therefore, current evidence does not support the clinical benefit of prophylactic hydroxychloroquine and shows a higher risk of adverse events.

PLOS ONE (2021)

Article Public, Environmental & Occupational Health

Use of hydroxychloroquine and chloroquine in patients with COVID-19: a meta-analysis of randomized clinical trials

Paulo Roberto Bignardi et al.

Summary: The use of hydroxychloroquine in the treatment of COVID-19 patients did not show significant effects on virological cure, clinical recovery, mortality, and adverse effects. However, patients who used hydroxychloroquine showed an increase in adverse effects.

PATHOGENS AND GLOBAL HEALTH (2021)

Review Immunology

The efficacy and safety of hydroxychloroquine (HCQ) in treatment of COVID19-a systematic review and meta-analysis

Anirban Hom Choudhuri et al.

Summary: This systematic review and meta-analysis did not confirm the significant impact of HCQ on survival, symptom alleviation, success in the presence of comorbidities, and conversion of RT PCR positivity to negativity in COVID-19 patients. Additionally, HCQ recipients were found to have a higher risk of cardiac side effects.

INDIAN JOURNAL OF MEDICAL MICROBIOLOGY (2021)

Review Respiratory System

Hydroxychloroquine and chloroquine for treatment of coronavirus disease 19 (COVID-19): a systematic review and meta-analysis of randomized and non-randomized controlled trials

Risa Ebina-Shibuya et al.

Summary: This study evaluated the treatment effect of hydroxychloroquine (HCQ) and chloroquine (CQ) for COVID-19 patients and found that these drugs failed to reduce all-cause mortality, did not improve viral clearance, but increased the risk of adverse events. Routine administration of HCQ/CQ for COVID-19 patients is not recommended.

JOURNAL OF THORACIC DISEASE (2021)

Review Cell Biology

Lysosomes as dynamic regulators of cell and organismal homeostasis

Andrea Ballabio et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)

Article Psychology, Biological

Comparing meta-analyses and preregistered multiple-laboratory replication projects

Amanda Kvarven et al.

NATURE HUMAN BEHAVIOUR (2020)

Article Infectious Diseases

The epidemiology, diagnosis and treatment of COVID-19

Pan Zhai et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Article Infectious Diseases

New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?

Christian A. Devaux et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Article Infectious Diseases

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Philippe Gautret et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Editorial Material Medicine, General & Internal

Chloroquine and hydroxychloroquine in covid-19

Robin E. Ferner et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Infectious Diseases

Impact of medical care, including use of anti-infective agents, on prognosis of COVID-19 hospitalized patients over time

Benjamin Davido et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Review Critical Care Medicine

A systematic review on the ef ficacy and safety of chloroquine for the treatment of COVID-19

Andrea Cortegiani et al.

JOURNAL OF CRITICAL CARE (2020)

Review Respiratory System

The Outcome of Hydroxychloroquine in Patients Treated for COVID-19: Systematic Review and Meta-Analysis

Teshale Ayele Mega et al.

CANADIAN RESPIRATORY JOURNAL (2020)

Review Health Care Sciences & Services

Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis

Arunmozhimaran Elavarasi et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2020)

Review Medicine, General & Internal

The Role of Hydroxychloroquine in COVID-19 Treatment: A Systematic Review and Meta-Analysis

Amir Shamshirian et al.

ANNALS ACADEMY OF MEDICINE SINGAPORE (2020)

Review Immunology

Effect of chloroquine and hydroxychloroquine on COVID-19 virological outcomes: An updated meta-analysis

Rashmi Ranjan Das et al.

INDIAN JOURNAL OF MEDICAL MICROBIOLOGY (2020)

Article Medicine, Research & Experimental

Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19

Joseph Magagnoli et al.

Review Endocrinology & Metabolism

No benefit of hydroxychloroquine in COVID-19: Results of Systematic Review and Meta-Analysis of Randomized Controlled Trials

Subodh Kumar Pathak et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)

Review Endocrinology & Metabolism

Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis

Awadhesh Kumar Singh et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)

Article Medicine, General & Internal

A Meta-Analysis on the Effects of Hydroxychloroquine on COVID-19

Nowair Hussain et al.

CUREUS JOURNAL OF MEDICAL SCIENCE (2020)

Article Biology

Quantifying publication bias in meta-analysis

Lifeng Lin et al.

BIOMETRICS (2018)

Article Psychology, Multidisciplinary

Conducting Meta-Analyses Based on p Values: Reservations and Recommendations for Applying p-Uniform and p-Curve

Robbie C. M. van Aert et al.

PERSPECTIVES ON PSYCHOLOGICAL SCIENCE (2016)

Article Psychology, Multidisciplinary

Meta-Analysis Using Effect Size Distributions of Only Statistically Significant Studies

Marcel A. L. M. van Assen et al.

PSYCHOLOGICAL METHODS (2015)

Article Psychology, Experimental

P-Curve: A Key to the File-Drawer

Uri Simonsohn et al.

JOURNAL OF EXPERIMENTAL PSYCHOLOGY-GENERAL (2014)

Review Neurosciences

Power failure: why small sample size undermines the reliability of neuroscience

Katherine S. Button et al.

NATURE REVIEWS NEUROSCIENCE (2013)

Review Medicine, General & Internal

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

PLOS MEDICINE (2009)

Editorial Material Medicine, General & Internal

Research methodology - Reasons or excuses for avoiding meta-analysis in forest plots

John P. A. Ioannidis et al.

BMJ-BRITISH MEDICAL JOURNAL (2008)